http://lookfordiagnosis.com
English
Spanish
Italian
Portuguese
French
Swedish
SYLVANT™ (siltuximab) Receives FDA Approval to Treat Multicentric ...
The warnings and precautions for SYLVANT include concurrent active severe infections, administration of live vaccines, infusion related reactions and hypersensitivity and gastrointestinal perforation.1 For more information about warnings and ...
PR Newswire (press release) - Wed, 23 Apr 2014 14:17

Zogenix Responds to Governor's Action Singling Out Zohydro(TM) ER in ...
Zohydro ER is contraindicated in patients with: significant respiratory depression; acute or severe bronchial asthma or hypercarbia; known or suspected paralytic ileus; and hypersensitivity to hydrocodone bitartrate or any other ingredients in Zohydro ER.
Wall Street Journal - Wed, 23 Apr 2014 04:36

Dahr Jamail | BP: Four Years On, No Restoration in Sight
... the symptoms, and I would expect to see increased rates of early-term miscarriages for women, early developmental issues for children born to women who were exposed to breathing these fumes and vapors, and also continuing chemical hypersensitivity ...
Truth-Out - Mon, 21 Apr 2014 06:12

Miley Cyrus Hospital Stay Extended; Did She Come Close to Dying?
The drug she took, Cephalexin, is typically used to treat infections caused by bacteria such as pneumonia, upper respiratory tract and bone, ear, skin and urinary tract infections, according to WebMD. Miley Cyrus Flashes Toned Shape; Here's How She Got ...
Celebrity Health & Fitness - Tue, 22 Apr 2014 22:37

GSK and Theravance announce phase III study of fluticasone furoate/vilanterol ...
FF/VI is contraindicated in patients with hypersensitivity to fluticasone furoate, vilanterol, or any of the excipients and in patients with infections or deep mycosis against which there is no effective anti-bacterial agent (symptoms may be ...
EIN News (press release) - Tue, 22 Apr 2014 06:10



FDA Approves Merck's RAGWITEK™ (Short Ragweed Pollen Allergen Extract ...
... asthma; a history of any severe systemic allergic reaction; a history of any severe local reaction after taking any sublingual allergen immunotherapy; a history of eosinophilic esophagitis; or hypersensitivity to any of the inactive ingredients ...
MarketWatch - Thu, 17 Apr 2014 15:23

FDA Approves Merck's RAGWITEK(TM) (Short Ragweed Pollen Allergen Extract ...
Wall Street Journal - Thu, 17 Apr 2014 15:27

GSK announces approval in Canada for Incruse™ Ellipta™ (umeclidinium) as a ...
For over 40 years GSK has been at the forefront of research and development of new respiratory medicines, and our goal in COPD is to introduce a range of medicines so that physicians can choose the treatment option which best meets their individual ...
Canada NewsWire (press release) - Thu, 17 Apr 2014 08:33

GSK announces approval in Canada for Incruse Ellipta (umeclidinium) as a ...
Wall Street Journal - Thu, 17 Apr 2014 10:10

FDA Approves Merck's Allergy Treatment
GRASTEK is contraindicated in patients with severe, unstable or uncontrolled asthma; a history of any severe systemic allergic reaction; a history of any severe local reaction after taking any sublingual allergen immunotherapy; a history of ...
Pharmaceutical Processing - Mon, 14 Apr 2014 14:56


1  2  3  4  5  6  7  8    ->

Last update: April 2009
Statistics